Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Presentation TCT 2024

TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry

Presenter: Yasser Sammour

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

Position 2: Ischemia and Viability Assessment Remain the Key to Guiding Revascularization

Presenter: James Udelson

October 24, 2023

Presentation TCT 2023

Position 1: Ischemia and Viability Testing Are Overrated – Clinical Judgement Should Guide Patient Management

Presenter: William Lombardi

October 24, 2023

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News TCT 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Shelley Wood

September 23, 2018

Presentation TCT 2017

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

November 01, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

Presentation TCT 2016

Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial?

Presenter: Ted Feldman, Allan Schwartz, JoAnn Lindenfeld

October 30, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

Presentation TCT 2012

All Arterial Revascularization: Is It Really Worth the Effort?

Presenter: Stephanie Mick

October 24, 2012

Advertisement

What’s Going to Be Hot at TCT 2025

TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry

What’s Going to Be Big at TCT 2024?

Position 2: Ischemia and Viability Assessment Remain the Key to Guiding Revascularization

Position 1: Ischemia and Viability Testing Are Overrated – Clinical Judgement Should Guide Patient Management

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial?

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

All Arterial Revascularization: Is It Really Worth the Effort?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content